| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |